The Europe Tranexamic Acid market was valued at US$ 245.6 million in 2024 and is projected to reach US$ 345.4 million by 2030, at a CAGR of 5.8%
Tranexamic Acid is a synthetic amino acid derivative used as an antifibrinolytic medication. This pharmaceutical compound effectively controls bleeding in various clinical settings. Modern formulations include various delivery systems and improved stability profiles.
Healthcare leads with 55% market share, followed by pharmaceuticals (30%) and research (8%). Germany leads with 35% share. Clinical applications expanded 42% since 2022. R&D reached 72 million.
Download FREE Sample of this Report @ https://www.24chemicalresearch.com/downloadsample/285462/europe-tranexamic-acid-forecast-market-2025-2030-857
Report Includes
This report is an essential reference for who looks for detailed information on Europe Tranexamic Acid. The report covers data on Europe markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Europe major vendors¡¯ information. In addition to the data part, the report also provides overview of Tranexamic Acid, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.
This report aims to provide a comprehensive presentation of the Europe Tranexamic Acid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tranexamic Acid. This report contains market size and forecasts of Tranexamic Acid in Europe, including the following market information:
We surveyed the Tranexamic Acid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment: by Country
• Germany
• United Kingdom
• France
• Italy
• Spain
• Netherlands
• Belgium
EUROPE TRANEXAMIC ACID MARKET
by Products type:
• USP25
• BP2000
• Other by Application:
• Trauma
• Craniocerebral Trauma
• Menorrhagia
• Postpartum Hemorrhage
• Surgery
• Other Treatment
• Whitening Cosmetics
key players include: (At least 8-10 companies included)
• Sanofi
• Pfizer Inc.
• Bayer AG
• CSL Behring
• Ferring Pharmaceuticals
• Octapharma
• Sobi - Swedish Orphan Biovitrum
• Grifols SA
• Takeda Pharmaceutical Company
• LFB Group
Including or excluding key companies relevant to your analysis.
Competitor Analysis
The report also provides analysis of leading market participants including:
• Key companies Tranexamic Acid revenues in Europe market, 2019-2024 (Estimated), ($ millions)
• Key companies Tranexamic Acid revenues share in Europe market, 2023 (%)
• Key companies Tranexamic Acid sales in Europe market, 2019-2024 (Estimated),
• Key companies Tranexamic Acid sales share in Europe market, 2023 (%)
EUROPE TRANEXAMIC ACID MARKET
Key Points of this Report:
• The depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis
• The report covers Europe and country-wise market of Tranexamic Acid
• It describes present situation, historical background and future forecast
• Comprehensive data showing Tranexamic Acid capacities, production, consumption, trade statistics, and prices in the recent years are provided
• The report indicates a wealth of information on Tranexamic Acid manufacturers
• Tranexamic Acid forecast for next five years, including market volumes and prices is also provided
• Raw Material Supply and Downstream Consumer Information is also included
• Any other user's requirements which is feasible for us
Reasons to Purchase this Report:
• Analyzing the outlook of the market with the recent trends and SWOT analysis
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
• Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
• Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
• Distribution Channel sales Analysis by Value
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• 1-year analyst support, along with the data support in excel format.
Get the Complete Report & TOC @ https://www.24chemicalresearch.com/reports/285462/europe-tranexamic-acid-forecastmarket-2025-2030-857
Table of content
1 Market Overview
1.1 Product Overview and Scope of Tranexamic Acid
EUROPE TRANEXAMIC ACID MARKET
1.2 Segment by Type
1.2.1 Europe Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 USP25
1.2.3 BP2000
1.2.4 Other
1.3 Segment by Application
1.3.1 Europe Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Trauma
1.3.3 Craniocerebral Trauma
1.3.4 Menorrhagia
1.3.5 Postpartum Hemorrhage
1.3.6 Surgery
1.3.7 Other Treatment
1.3.8 Whitening Cosmetics
1.4 Europe Market Growth Prospects
1.4.1 Europe Revenue Estimates and Forecasts (2019-2030)
1.4.2 Europe Production Estimates and Forecasts (2019-2030)
2 Europe Growth Trends
EUROPE TRANEXAMIC ACID MARKET
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
CONTACT US:
North Main Road Koregaon Park, Pune, India - 411001.
International: +1(646)-781-7170
Asia: +91 9169162030
Follow Us On linkedin :- https://www.linkedin.com/company/24chemicalresearch/
